rs2245466
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_004310.5(RHOH):c.-405G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004310.5 5_prime_UTR
Scores
Clinical Significance
Conservation
Publications
- epidermodysplasia verruciformis, susceptibility to, 4Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
- epidermodysplasia verruciformisInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- T-cell immunodeficiency with epidermodysplasia verruciformisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004310.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RHOH | TSL:1 MANE Select | c.-405G>A | 5_prime_UTR | Exon 1 of 3 | ENSP00000371219.4 | Q15669 | |||
| RHOH | TSL:4 | c.-405G>A | 5_prime_UTR | Exon 2 of 4 | ENSP00000514769.1 | Q15669 | |||
| RHOH | TSL:3 | c.-587G>A | 5_prime_UTR | Exon 2 of 5 | ENSP00000422241.2 | Q15669 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 152054Hom.: 0 Cov.: 33
GnomAD4 exome Cov.: 0
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 152054Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74270
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.